Investor Information
DendroTEK Biosciences is a privately funded life sciences company focused on the cationic cell culture surface market, addressing long standing limitations in stability and reproducibility for advanced in vitro models.
The company is currently operating on a nondilutive basis and is supported by McGill University and the McGill Innovation Fund. Built on peer reviewed academic research and early commercial traction, DendroTEK is executing a disciplined, science led growth strategy.
For investor inquiries and additional information, please contact info@dendrotek.ca